WSOP taps Solana to add crypto payments at poker events
The World Series of Poker has partnered with the Solana Foundation to bring cryptocurrency payments into its tournament operations for the first time.
The World Series of Poker has partnered with the Solana Foundation to bring cryptocurrency payments into its tournament operations for the first time.
Comstock (NASDAQ:CHCI) announced a definitive agreement with Jericho Energy Ventures to establish a joint venture named Oklahoma AI Ventures, aiming to develop mega-scale artificial intelligence data center campuses in rural Oklahoma.
Danaher (NYSE:DHR), a global science and technology innovator, announced that it has completed the acquisition of Masimo (NASDAQ:MASI), a specialty diagnostics provider known for pulse oximetry and other patient monitoring solutions in acute care settings.
Prenetics Global (NASDAQ:PRE), the parent company of the IM8 premium health and longevity brand, reported first-quarter 2026 revenue of $36 million, with IM8 contributing $33.8 million.
HEICO (NYSE:HEI) announced that its Exxelia subsidiary has acquired a 90% stake in CalRamic Technologies, a Reno, Nevada-based manufacturer of high-voltage ceramic capacitors.
T. Rowe Price Group (NASDAQ:TROW) reported month-end assets under management (AUM) of $1.89 trillion as of May 31, 2026.
ParaZero Technologies (NASDAQ:PRZO) announced that it has secured two purchase orders in Israel for its DefendAir Net Pod system, marking a significant step in integrating its autonomous Counter-UAS technology into advanced defense platforms.
Paramount Skydance's (NASDAQ:PSKY) proposed $110 billion acquisition of Warner Bros. Discovery (NASDAQ:WBD) has come under formal scrutiny from the European Union over its financial backing from Middle Eastern sovereign wealth funds, according to a European Commission filing.
Figure Technology Solutions (NASDAQ:FIGR) announced a definitive agreement to acquire Kiavi, an AI-powered lending platform tailored for residential real estate investors, in a transaction valued at $717 million.
Scinai Immunotherapeutics (NASDAQ:SCNI) reported a net profit for the first quarter of fiscal year 2026, driven primarily by a substantial, non-cash accounting gain linked to its recent acquisition of Recipharm Israel.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas